Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

473
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
473
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

413
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
413

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes of Pre-Transplant Cardiac Prehabilitation in the ICU on Impella 5.5.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Left Ventricular Assist Device Emergencies: Diagnosis and Management.

Cardiac electrophysiology clinics·2026
Same author

Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients.

JACC. CardioOncology·2026
Same author

Electrocardiographic parameters and outcomes in patients with cardiac amyloidosis and implantable cardioverter defibrillators.

Journal of electrocardiology·2026
Same author

An Overview of Vascular Compression Syndromes and Associations with Autonomic Dysfunction: A Review.

Biomedicines·2026
Same author

Teclistamab Treatment Followed by Heart Transplantation for Advanced Immunoglobulin Light Chain Amyloid Cardiomyopathy.

JACC. Case reports·2026

Related Experiment Video

Updated: Jan 14, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K

Addressing Comorbidities in Heart Failure.

Rachel Tobin1, Petra Rantanen2, Melissa Lyle3

  • 1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

The Medical Clinics of North America
|October 24, 2025
PubMed
Summary

Managing heart failure (HF) comorbidities is crucial. Addressing these common conditions improves patient outcomes and reduces healthcare utilization for heart failure patients.

Keywords:
AnemiaAtrial fibrillationChronic kidney diseaseComorbiditiesDiabetesHeart failureHypertensionManagement

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

523
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K

Related Experiment Videos

Last Updated: Jan 14, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

523
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Practice

Background:

  • Heart failure (HF) frequently co-occurs with other medical conditions (comorbidities).
  • These comorbidities significantly complicate patient management and worsen prognosis.
  • Common comorbidities increase medication complexity, adverse drug events, and healthcare resource use.

Purpose of the Study:

  • To highlight the prevalence and impact of comorbidities in heart failure.
  • To emphasize the need for clinicians to understand and manage these coexisting conditions.
  • To improve overall care quality and patient outcomes in heart failure.

Main Methods:

  • Literature review on heart failure comorbidities.
  • Analysis of clinical impact and management strategies.
  • Synthesis of current evidence for optimal patient care.

Main Results:

  • Comorbidities are highly prevalent in heart failure patients.
  • Associated with increased mortality, hospitalizations, and reduced quality of life.
  • Effective management strategies are essential for mitigating adverse outcomes.

Conclusions:

  • Optimal heart failure care necessitates addressing common comorbidities.
  • Understanding comorbidity management improves patient prognosis.
  • Clinicians require knowledge of comorbidity interactions to prevent adverse events.